STW 5 (Iberogast®) is a phytotherapeutic combination of nine herbal extracts and used
in the treatment of functional gastrointestinal diseases i.e. motility disturbances. ProstaglandinF2α (PGF2α), a pro-inflammatory mediator, has been shown to play an important role in modulating
intestinal motility under physiological as well as under pathophysiological conditions
[1]. The aim of this study is to determine the effects of STW 5 and its herbal components
on the PGF2α-induced contractile activity in mouse ileum.
Smooth muscle rings of the ileum are mounted in a perfused organ bath and longitudinal
spontaneous peristaltic activity and tonus are recorded. First the effect of PGF2α [10-6 M] on the ileum is measured thus obtaining the control response, then the application
is repeated to the same sample pretreated with different herbal extracts and STW 5
(diluted 1:100), respectively. Each tissue specimen is used for only one extract.
The preparations show a very stable spontaneous peristaltic contractility (mean amplitude
5.8±2 mN; mean frequency 25±5/minute). PGF2α induces a transient tonic contraction with a low increase of frequency of the spontaneous
peristaltic activity. The plant extracts influence PGF2α-induced contractility in different ways: peppermint, chamomile, angelica root and
milk thistle inhibit the PGF2α-induced tone as well as the amplitude of spontaneous contractility, whereas liquorice
root and melissa show a minor effect on these measurement parameter. The combination
STW 5 inhibits mainly the PGF2α-induced tonic contraction.
STW 5 (Iberogast®) and its components can inhibit the PGF2α-induced contraction. These findings suggest a spasmolytic activity of STW 5 in irritable
bowel syndrome and inflammation induced increased motility.
Acknowledgement: Supported by Alfred Teufel-Stiftung, Nagold, Germany
References: 1. Frantzides, C.T. et al. (1992), Am. J. Physiol. 262(3 Pt 1): G488–97.